Millennium Pharmacon International Capital Reinvestment Ratio
Millennium Pharmacon International capital reinvestment ratio. Millennium Pharmacon International (SDPC) has a Capital Reinvestment Ratio of 0.02x as of March 2025, meaning it reinvests 0% of its operating cash flow (Rp70.29 Billion) in capital expenditures (Rp1.09 Billion). Check Millennium Pharmacon International cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Millennium Pharmacon International (2004–2022)
Capital reinvestment ratio of Millennium Pharmacon International from 2004 to 2022. This chart tracks Millennium Pharmacon International's Capital Reinvestment Ratio across 8 annual periods. Also explore how fast is Millennium Pharmacon International growing its equity to track the company's year-over-year net asset growth rate.
Millennium Pharmacon International Capital Reinvestment Ratio by Year (2004–2022)
Millennium Pharmacon International capital reinvestment ratio by year from 2004 to 2022. For the full cash flow conversion analysis, see SDPC cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.36x | Rp41.00 Billion | Rp14.68 Billion | ▲ +573.3% |
| 2020 | 0.05x | Rp71.69 Billion | Rp3.81 Billion | ▼ -96.0% |
| 2018 | 1.35x | Rp4.72 Billion | Rp6.35 Billion | ▼ -9.3% |
| 2017 | 1.48x | Rp4.46 Billion | Rp6.61 Billion | ▲ +160.6% |
| 2012 | 0.57x | Rp2.19 Billion | Rp1.25 Billion | ▼ -21.3% |
| 2007 | 0.72x | Rp4.57 Billion | Rp3.31 Billion | ▼ -26.7% |
| 2006 | 0.99x | Rp802.62 Million | Rp792.17 Million | ▲ +59.7% |
| 2004 | 0.62x | Rp2.72 Billion | Rp1.68 Billion | — |